Evidence map›Paper›PMID 41991825›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Elisa Maria Piella, Alberto Mario Chiarandon, Maria Albanese, Enrica Maria Puddu, Francesca Pistoia, Gennaro Saporito, Marta Altieri, Giada Giuliani, Gloria Vaghi, Grazia Sances and 21 more

Abstract readValidation Study
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Elisa Maria PiellaHeadache Center, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy. elisamaria.piella@unito.it.ORCID http://orcid.org/0000-0002-0706-3632
Alberto Mario ChiarandonHeadache Center, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Maria AlbaneseUnit of Neurology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Enrica Maria PudduUnit of Neurology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Francesca PistoiaDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Gennaro SaporitoHeadache Center, San Salvatore Hospital, L'Aquila, Italy.
Marta AltieriDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Giada GiulianiDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Gloria VaghiDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Grazia SancesDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Antonio MunafòHeadache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy.
Alberto ChiarugiHeadache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy.
Raffaele OrnelloDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Federico De SantisDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Mariarosaria ValenteDMED, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy.
Renata RaoNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, BS, Italy.
Antonio RussoHeadache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Marcello SilvestroHeadache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Fausto RovetaHeadache Center, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Danilo Antonio MontisanoNeuroalgology Unit and Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Licia GrazziNeuroalgology Unit and Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Stefania BattistiniDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Francesca BoscainHeadache Centre, Neurology-Euganea, Health Unit, Padua, Italy.
Edoardo MampresoHeadache Centre, Neurology-Euganea, Health Unit, Padua, Italy.
Damiano Paolicelli"L. Amaducci" Neurological Clinics, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari, Bari, Italy.
Simona SaccoDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Cristina TassorelliDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Elisa RubinoHeadache Center, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Maria Pia Prudenzano"L. Amaducci" Neurological Clinics, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari, Bari, Italy.
Innocenzo RaineroHeadache Center, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Italian Headache Registry (RICe) Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Migraine Interictal Burden Scale (MIBS-4) is a brief validated patient-reported measure of migraine interictal impact; however, an official Italian translation is not currently available.

methodsThe MIBS-4 was translated and culturally adapted into Italian language and psychometrically evaluated in adults with episodic or chronic migraine enrolled in the Italian Headache Registry (RICe). In a 4-week test–retest design, participants completed the Italian version of MIBS-4 and the Migraine Disability Assessment (MIDAS) at baseline (T0) and at follow up (T1). We assessed internal consistency, dimensionality, test–retest reliability, convergent validity, and known-groups validity across MIDAS disability grades.

resultsA total of 191 patients with migraine were included in test–retest analyses. Internal consistency was good to excellent (Cronbach’s α = 0.86 at T0; 0.90 at T1; ordinal α = 0.91–0.94; McDonald’s ω = 0.88–0.91). Parallel analysis supported a stable one-factor solution at both timepoints. Item-level agreement was moderate (weighted κ = 0.45–0.60; all p < 0.001), as was the total-score stability (ICC[A,1] = 0.62, 95% CI 0.50–0.72). Convergent validity with MIDAS was moderate (ρ = 0.40 at T0; ρ = 0.33 at T1; both p < 0.001). DISCUSSION: The present findings indicate that the Italian MIBS-4 is psychometrically robust and captures a dimension of migraine burden that is only partially explained by conventional attack-focused disability measures.

conclusionThe Italian version of MIBS-4 provides a reliable instrument for quantifying interictal burden in Italian-speaking migraine individuals, enabling a more comprehensive evaluation of migraine and supporting individualized management.

Indexed as

Migraine DisordersPsychometricsAdultCohort StudiesDisability EvaluationFemaleHumansItalyMaleMiddle AgedReproducibility of ResultsSeverity of Illness IndexSymptom BurdenTranslatingTranslationsBurdenInterictal periodMIBS-4MigraineValidation

Identifiers

PMID41991825
PMCPMC13086818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.